Reckitt Sales Hit by Lackluster US Demand for Cold Medicines
perigon
Last updated: April 22, 2026
Reckitt Benckiser Group Plc experienced a slowdown in sales growth, primarily attributed to a less severe cold and flu season in the United States and supply chain disruptions in the Middle East. This led to a modest increase in like-for-like sales.
- The company's like-for-like sales saw a minimal increase of 0.6% in the first quarter. This performance fell short of expectations, impacted by specific market challenges. The weak cold and flu season in the US significantly affected demand for relevant products. Concurrently, supply chain issues in the Middle East created further impediments to sales. These combined factors contributed to the slower-than-anticipated revenue growth for the quarter. The company is navigating these headwinds while focusing on its product portfolio and market strategies.
